Home page > Press Releases

Edit email address
Invalid email
Email Sent
 
Anvisa aprova a primeira combinação tripla fixa extrafina para tratamento da DPOC no Brasil.
-
1/9
ARCHIVE PRESS RELEASE
Grupo Chiesi é a maior empresa farmacêutica no mundo a ser premiada com a certificação B Corporation
Chiesi´s people management practices are recognized by global entity
Chiesi is the first pharmaceutical company recognized as “Pró-Ética
Innovative threatment for COPD has its first data published
For the second time, Chiesi’s extra fine fixed ICS/LABA/LAMA triple combination therapy wins a place in the pages of 'The Lancet', with the publication of the TRINITY study conducted by Chiesi.
Pharmaceutical company marks its 40th anniversary in Brazil with factory expansion
Chiesi joins the